Neurogenesis: HBHL New Faculty Recruit Speaker Series


 HBHL New Recruit Speaker Series in large white font

Register for the virtual event by Feb. 1 at 4:00 p.m.

Are you curious about new research from McGill neuroscience faculty? This monthly speaker series features recipients funding through Healthy Brains, Healthy Lives' New Recruit Start-Up Supplements Program, which provides faculties with additional start-up funding to attract outstanding new faculty recruits to McGill.


Headshot of Romina Mizrahi

Dr. Romina Mizrahi

Dr. Mizrahi's research seeks to understand early molecular changes in the brain of youth with psychosis, with the hope to identify new targets for prevention, intervention and treatment. Dr. Mizrahi has received numerous funds from the Canadian Institutes of Health Research, National Institute of Mental Health, and numerous foundations including the Brain and Behaviour Research foundation since she became an independent investigator in 2007. Dr. Mizrahi’s hopes to advance our understanding of how the brain functions in-vivo, in particular to understand the contribution of stress and drug use in youth.

Headshot of Yasser Iturria-Medina

Dr. Yasser Iturria-Medina

Dr. Iturria-Medina’s Lab – Neuroinformatics for Personalized Medicine – pursues primarily the goal of making precision medicine in Neurology a reality. It focuses on defining and implementing multiscale and multifactorial brain models for understanding neurological disorders and identifying effective personalized interventions. The lab combines molecular, imaging and cognitive data using integrative mathematical modelling to create both individual and population-based mechanistic brain models.

Iturria-Medina’s research has spanned neurodegeneration modelling, brain multimodal connectivity estimation, and statistical analysis for characterizing/predicting abnormal brain states. He currently is focusing on the creation and validation of integrative molecular, neuroimaging, and computational tools for understanding complex causal interactions among ageing, neurodegeneration and different therapeutic conditions.

Back to top